Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
1.51M
-
Shares change
-
-31.3K
-
Total reported value, excl. options
-
$1.46M
-
Value change
-
-$183K
-
Number of buys
-
9
-
Number of sells
-
-8
-
Price
-
$0.97
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q3 2019
26 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q3 2019.
IGC Pharma, Inc. - COM NEW (IGC) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.51M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (454K shares), GEODE CAPITAL MANAGEMENT, LLC (259K shares), Carroll Financial Associates, Inc. (215K shares), DEARBORN PARTNERS LLC (103K shares), NORTHERN TRUST CORP (93.6K shares), GOLDMAN SACHS GROUP INC (66.3K shares), Creative Planning (65.4K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (57.3K shares), BANK OF MONTREAL /CAN/ (45K shares), and CITADEL ADVISORS LLC (42.2K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.